Article
Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?
Targeted oncology - 1 Sept 2015
Allard M A, Saffroy R, de la Maisonneuve P Bouvet, Ricca L, Bosselut N, Hamelin J, Lecorche E, Bejarano M A, Innominato P, Sebagh M, Adam R, Morère J F, Lemoine A
Abstract excerpt
Recent data showed that metastatic colorectal (mCRC) tumors exhibiting extended RAS-BRAF mutations were resistant to anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, making these drugs suitable for the so-called "super" wild-type (WT) patients only. This study aimed to compare...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
